Researchers at the Washington University Tuberous Sclerosis Center conduct both laboratory and clinical research, with the goals of characterizing the clinical features of TSC, understanding the biological basis of the disease, and ultimately developing and testing novel treatments for patients with TSC.
Nicholas Rensing
Laboratory Research Supervisor
Laura Jansen, MD, PhD
Co-Investigator
PREVeNT Epilepsy Trial and Cannabidiol Clinical Trial
Olga Novak
Clinical Research Coordinator
Ashley Fasciola, RN, BSN
Nurse Research Coordinator
Robin Ryther, MD, PhD
Co-Investigator
EXIST3 Clinical Trial and Cannabidiol Clinical Trial
Thomas Foutz, MD, Phd
Laboratory Investigator
Dongjun Guo, MD, PhD
Laboratory Staff Scientist